Recent Updates
Recently added Catalysts
SANA Negative Sentiment Score: 20/100

Sana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – SANA

Key Takeaway: Sana Biotechnology, Inc. is being sued for alleged violations of securities laws, with investors encouraged to contact The Gross Law Firm for potential participation in class action. The lawsuit claims that the company misled shareholders regarding its financial position and the viability of certain drug candidates. Specifically, it alleges that Sana faces significant risks related to funding for operations and product development. The deadline for shareholders to register for the class action is May 20, 2025.

Market Sentiment Analysis

CONCERNS & RISKS

  • Sana Biotechnology is facing a lawsuit for securities law violations.
  • Allegations suggest the company misled investors about its financial stability and product potential.
  • There's a risk of funding cuts and layoffs affecting ongoing projects.
  • Statements from the defendants were deemed materially false and misleading.

Full Press Release Details

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
Shareholders who purchased shares of SANA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: March 17, 2023 to November 4, 2024
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Sana was at significant risk of having insufficient funds to maintain its current operations and advance one or more of its product candidates; (ii) SC291 in oncology, SC379, and SG299 were less promising than defendants had led investors to believe; (iii) in order to preserve cash and advance its more promising product candidates, Sana was likely to decrease funding for and/or discontinue SC291 in oncology, SC379, and SG299, as well as significantly reduce its headcount; (iv) accordingly, defendants overstated Sana’s financial capacity to maintain its current operations and advance its existing product candidates; and (v) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.
DEADLINE: May 20, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/sana-biotechnology-inc-loss-submission-form/?id=147117&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of SANA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is May 20, 2025. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
15 West 38th Street, 12th floor
Phone: (646) 453-8903

Tags

Frequently Asked Questions

What is the class period for Sana Biotechnology shareholders?

The class period for shareholders of Sana Biotechnology is from March 17, 2023, to November 4, 2024.

What allegations are made against Sana's management?

The allegations include misleading statements about financial viability and the true potential of product candidates.

How can shareholders register for the class action?

Shareholders can register through the provided link to enroll in the class action lawsuit.

Is there a deadline for lead plaintiff appointment?

Yes, the deadline to seek lead plaintiff status is May 20, 2025.

What support does the Gross Law Firm provide to shareholders?

The firm offers portfolio monitoring and case status updates to registered shareholders.

Last updated: May 7, 2025